Guido Dalbagni, M.D., FACS
Department of Urology Memorial Sloan-Kettering Cancer Center

Dr. Guido  Dalbagni is a surgeon with expertise in the treatment of urologic tumors. His  primary areas of interest are bladder cancer and bladder reconstruction following  surgery. He  is  currently heading clinical trials at Memorial Sloan-Kettering to evaluate new  therapies for the treatment of high-risk superficial bladder cancer in patients who are resistant  to bacillus Calmette-Guérin (BCG) therapy, the standard treatment.
Click here for more information.

Share this page:Share on FacebookTweet about this on TwitterShare on Google+Share on TumblrShare on LinkedInEmail this to someone